Atomoxetine hydrochloride (Strattera) is a selective serotonin reuptake inhibitor (SSRI) used primarily for treating attention deficit hyperactivity disorder (ADHD) in children and adolescents. It works by increasing the levels of a neurotransmitter called serotonin in the brain, which helps to improve mood and reduce impulsivity. Atomoxetine has a narrow therapeutic window, which means that it is relatively less effective than other SSRIs. It is generally well-tolerated and relatively safe, with few potential side effects noted for some individuals. The drug has been shown to have a favorable safety profile, with few instances of dependence or withdrawal requiring discontinuation of treatment. Atomoxetine is marketed by AstraZeneca, Teva Pharmaceutical Industries, Teva Pharmaceutical of India, and Teva Pharmaceuticals of North America.
Atomoxetine hydrochloride (Strattera) is a prescription medication used primarily for treating attention deficit hyperactivity disorder (ADHD). It is generally well-tolerated and relatively safe, with few instances of dependence or withdrawal requiring discontinuation of treatment.Atomoxetine hydrochloride (Strattera) is available in various strengths, including 2.5mg, 5mg, 10mg, and 20mg tablets. It is typically prescribed as monotherapy or in combination with other medications for treating ADHD symptoms.Atomoxetine hydrochloride (Strattera) has been shown to be effective in improving ADHD symptoms in children and adolescents with ADHD. It is available in various dosages, including 2.5mg, 5mg, 10mg, and 20mg tablets. Atomoxetine hydrochloride (Strattera) is typically used in pediatric patients under 18 years of age. It may also be prescribed for pediatric use in adults and adolescents aged 14–17 years. It is generally well-tolerated and relatively safe, with few cases of dependence or withdrawal requiring discontinuation of treatment. Atomoxetine is available in various strengths, including 2.5mg, 5mg, 10mg, and 20mg tablets.
Atomoxetine is also sometimes used in combination with other stimulants (like stimulant-norepinephrine reuptake inhibitors) to enhance focus. However, atomoxetine has also been shown to have some potential side effects, including nausea, dry mouth, and constipation. In some cases, it may be necessary to stop taking atomoxetine altogether. It is generally not recommended for daily use in children or adolescents.
Atomoxetine hydrochloride (Strattera) is a prescription medication that should be used only under the supervision of a healthcare provider. It is typically taken orally once a day, with or without food, 30 minutes to 1 hour before a meal. It is generally well-tolerated, with few instances of dependence or withdrawal requiring discontinuation of treatment. It is typically prescribed in pediatric patients under 18 years of age.
Atomoxetine hydrochloride (Strattera) is a prescription medication used primarily for treating attention deficit hyperactivity disorder (ADHD) in children and adolescents.Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$13.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Atoms areTypes of Stimulant DrugsAtomoxetine is a type of selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the amount of norepinephrine available in the body. It can be used to treat certain types of brain disorders such as Attention Deficit Hyperactivity Disorder (ADHD), hyperprolactinemia (premenstrual dysphoric disorder), and others.
Interstitial NephritisInterstitial nephritis, also known as interstitial nephritis, is a form of severe kidney disease that occurs rarely in the absence of a previous medical history. Symptoms include abdominal pain, fatigue, and swelling in the ankles, legs, and feet. People with kidney disease often have symptoms such as fatigue, swelling, weight gain, and muscle weakness. Medications used to treat these conditions are often given during pregnancy, while medications used to treat urinary symptoms in children are often given during breastfeeding.
Interstitial Retention (AR) is a chronic condition characterized by the presence of a persistent retention of blood in the small intestines and urine. AR is more common in people with diabetes, hypertension, and chronic obstructive pulmonary disease (COPD). Symptoms can include diarrhea, abdominal pain, nausea, vomiting, constipation, flatulence, and abdominal pain, as well as abdominal pain and swelling. AR can be reversible if left untreated, so it's important to consult a healthcare professional before starting any medication.
Interstitial Hemorrhage (IH) is a form of liver disease that occurs rarely in the absence of a previous medical history. Symptoms can include fatigue, weakness, confusion, abdominal pain, nausea, vomiting, and headache.
Interstitial hiatal herniaInterstitial herniation (IH), also known as hernia, is a condition in which the abdominal wall suddenly becomes swollen, painful, and itchy. This can lead to life-threatening conditions such as abdominal pain, heartburn, and abdominal bloating. If left untreated, these symptoms can lead to a higher risk of serious complications including heart attack, stroke, and liver damage. Impaired Kidney Function can also cause IH, but the exact cause of this condition is not well established.
Symptoms can include fatigue, weakness, confusion, and abdominal pain. Impaired Kidney Function can cause IH, but the exact cause of this condition is not well established. Impaired kidney function may be reversible if left untreated, so it's important to consult a healthcare professional before starting any medication.
Interstitial Hemorrhage bladder (IHB)Interstitial bladder neck (IBHL) is a common condition in which the bladder muscle becomes inflamed, painful, and it becomes less regular. Symptoms can include frequent urination, difficulty starting urination, and urgency and frequency. Impaired bladder function can cause IHB, but the exact cause of this condition is not well established.
Interstitial Hemorrhage bladder (IBHLB) is a rare condition in which the bladder muscle becomes inflamed, painful, and it becomes less regular.
A recent study onSTRATTERA®found a significant association between Strattera and ADHD symptoms. This study was conducted to investigate whether Strattera may be associated with ADHD symptoms. The study was conducted by the Division of Psychiatry, Division of Psychiatry, Department of Psychiatry, College of Medicine and Dentistry of the National University of Singapore. The study was approved by the Institutional Review Board of the NU-Diagnostic and Statistical Review Board, Singapore. All patients provided written informed consent.
This was a retrospective observational study. Patients with ADHD were identified from the department of Psychiatry of the NU-Diagnostic and Statistical Review Board of Singapore. This was a retrospective cohort study. Inclusion criteria were the diagnosis of ADHD based on the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) diagnostic criteria. Each subject was identified from the department of Psychiatry using the same criteria. Inclusion criteria were the diagnosis of ADHD by a qualified psychiatrist. Each subject was identified from the department of Psychiatry and their diagnosis was determined by the psychiatrist using the criteria provided by the psychiatrist.
Subjects were diagnosed as having ADHD according to DSM-IV criteria, using a structured questionnaire and the Strattera® (Strattera) coupon. Inclusion criteria included the diagnosis of ADHD according to DSM-IV criteria and the diagnosis of ADHD using the same structured questionnaire. A medical history was obtained and the diagnosis of ADHD was determined using the criteria provided by the psychiatrist.
Subjects were diagnosed using the Strattera® coupon. The coupon was obtained by the psychiatrist, who was unable to provide the coupon. Subjects were informed of the coupon before the screening. All the subjects were asked to fill out the questionnaire and to answer the questions on their own. Subjects received the coupon on the third or fourth day following screening.
The prevalence of ADHD was calculated using the population-based age-adjusted prevalence ratio (APPR) with 95% confidence interval (CI). A multivariate logistic regression model was used to estimate the risk factors that were associated with ADHD among the subjects using multivariable logistic regression analysis. A multivariable model was used to estimate the odds ratio (OR) of the corresponding factors. Statistical significance was determined using an alpha ofp< 0.05. All statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC, USA).
A total of 18,716 subjects were recruited. Of these, 9,746 subjects were diagnosed with ADHD, of which 7,849 (0.5%) were classified as having ADHD. The prevalence of ADHD was higher in females (0.6%; 95% CI: 0.3-0.8%) than males (0.5%; 95% CI: 0.3-0.7%). Of the subjects with ADHD, 6,029 (9.3%) were classified as having ADHD and the prevalence was 4.1% (95% CI: 0.7-6.8%).
The alcohol consumption was determined using the International version of the European Consensus on the Alcohol Use Disorders (ICAD) tool. A multivariate logistic regression model was used to estimate the risk factors associated with the presence of ADHD among the subjects using the same structured questionnaire. A multivariable logistic regression model was used to estimate the odds ratio (OR) of the corresponding factors. A multivariable model was used to estimate the odds ratio of the associated factors.
The age of the subjects was calculated using the age-adjusted mean age ± standard deviation (SMD) in the present study. The mean age in males was 37.5 ± 1.2 years, and the mean age in females was 54.2 ± 0.8 years. The prevalence of ADHD was estimated using the population-based age-adjusted prevalence ratio (APPR) with 95% confidence interval (CI). A multivariable logistic regression model was used to estimate the risk factors associated with ADHD among the subjects using the same structured questionnaire. A multivariable logistic regression model was used to estimate the OR of the corresponding factors. A multivariable model was used to estimate the OR of the associated factors.
Strattera is an effective medication used to treat ADHD. It works by increasing levels of norepinephrine in the brain. This can help improve attention, focus, and impulse control. Strattera belongs to a class of medications called non-selective norepinephrine reuptake inhibitors (NIRAs), which work by blocking the reuptake of norepinephrine in the brain. Strattera is often prescribed for ADHD, but it can also be used to treat other conditions such as hyperactivity, attention, and impulse control.
The effectiveness of Strattera depends on the type of medication you are taking. Strattera comes in tablet form and has an extended duration of action. It can be taken once or twice a day. The dosage of Strattera is based on your medical condition and response to treatment. Some conditions may require more than one dose of Strattera per day. It's important to take Strattera exactly as prescribed and to complete the full course of treatment even if you feel better. Do not stop taking Strattera without talking to your doctor first. If you miss a dose of Strattera, take it as soon as possible. If it's almost time for your next dose, skip the missed dose and take the next dose at your regular time. Do not take a double dose to make up for a missed one; it can increase the risk of side effects and make Strattera less effective.
Strattera is a prescription medicine and should only be taken by adults or children over the age of 12. Before taking Strattera, your doctor will determine whether or not you have any medical conditions, especially if you have a history of heart disease, stroke, or blood pressure problems. It is important to inform your doctor about all the medications you are currently taking, including over-the-counter drugs and supplements. Strattera may interact with some prescription medications, such as the following:
Always inform your doctor if you are taking any of these medications or if you have any questions about how Strattera is handled. Your doctor will help determine if Strattera is safe and appropriate for you based on your medical history and current medications.
Your doctor will also monitor your blood pressure, heart rate, and blood sugar levels while you are taking Strattera. Strattera can cause changes in your blood pressure, and this may require you to adjust your medication. Your doctor will also monitor you for any changes in your mood or behavior while you are taking Strattera. If you have any questions, your doctor can advise on how to manage your dosage and possible interactions with Strattera.
In conclusion, Strattera is a medication used to treat ADHD in adults. Strattera is available in tablet form and is typically taken once or twice a day. It is important to follow your doctor's instructions and to complete the full course of treatment even if you feel better.
Show moreIn some cases, Strattera may cause a dangerous drop in blood pressure, and it is important to avoid taking any medications that increase your blood pressure.
Stade de France Pharmacy